Magellan Spine Technologies, Inc. announced today receipt of the CE Mark for the Company’s DART™ Disc Annular Repair Technology System. This patented technology is used to seal the access site in the annulus fibrosus following lumbar spine microdiscectomy.
CE Mark Approval
Bolton Medical Obtains CE Mark for the New RELAY Plus Thoracic Stent-Graft Delivery System
At the recent Charing Cross Symposium in London, Bolton Medical announced the launch of a new and further improved delivery system: RELAY Plus.
Minnow Medical Receives CE Mark For Guided Re-Shaping Catheter To Treat Peripheral Artery Disease
Minnow Medical, a developer of innovative products to treat artery disease, announced it has received the CE Mark clearing its disposable catheter for marketing in the European Union.
Cardima Receives CE Mark Approval for its Surgical Ablation Probe with Stabilization Sheath
Cardima, Inc., a medical device company focused on the treatment of atrial fibrillation and manufacturer of the Cardima Surgical Ablation System, today announced that it has received CE Mark approval for its Surgical Ablation Probe with Stabilization Sheath.
Medtronic Announces International Market Release of Driver Sprint RX Coronary Stent System
Medtronic, Inc. today began the international launch of the Driver Sprint RX Coronary Stent System, which received the CE Mark in February 2009 and is planned to be commercially available in more than 100 countries worldwide.
SenoRx Announces CE Mark to Commercialise Contura™ MLB in Europe
SenoRx today announced that it has received the right to apply the CE Mark to its Contura(tm) MLB short-term breast radiation balloon catheter.
OrSense Receives European CE Mark Approval For New Monitoring System
OrSense Ltd. announced today that it has received a European CE Mark approval for its NBM-200MP, a Continuous Non-Invasive Hemoglobin And Pulse Oximetry Monitoring System.
NeuroVasx Receives CE Mark for cPAX Aneurysm Treatment System
NeuroVasx, Inc., a medical device company that develops technologies for the treatment of hemorrhagic and ischemic stroke, announced today that it has received CE Mark for the cPAX Aneurysm Treatment System.
IlluminOss™ Photodynamic Bone Stabilization System Receives CE Mark
IlluminOss Medical Inc., a medical device company developing the innovative IlluminOss™ Photodynamic Bone Stabilization System for orthopedic surgery, today announced that it had been granted a CE Mark.
XTENT Receives CE Mark Approval for CUSTOM NX ® Drug-Eluting Stent System
XTENT, Inc. today announced that it has received CE Mark approval for its CUSTOM NX drug-eluting stent (DES) System.
Invatec Receives CE-Mark For Second Drug-Eluting Balloon Platform
Invatec, a comprehensive innovator of interventional products, announced CE-certification of a new coronary balloon, the IN.PACT™ Falcon paclitaxel-eluting PTCA balloon catheter.
Arobella Medical Announces European CE Mark Approval of Qoustic Wound Therapy System™
Arobella Medical, LLC, announced European CE Mark approval of its Qoustic Wound Therapy System™ medical device for ultrasound aided wound care.
St. Jude Medical Announces European CE Mark Approval of Neurostimulation System for Chronic Angina
St. Jude Medical, Inc. today announced European CE Mark approval of its Genesis® neurostimulation system for managing a form of chest pain known as chronic angina pectoris, or chronic angina.
Angiotech announces Positive Results from Bio-Seal™ Clinical Study
Angiotech Pharmaceuticals, Inc. today announced positive clinical study results for its Bio-Seal™ Lung Biopsy Tract Plug System at the
Society of Interventional Radiologists Annual Scientific Meeting in San Diego, CA.
Flexible Stenting Solutions, Inc. Receives CE Mark for New FlexStent Biliary Self Expanding Stent System
Flexible Stenting Solutions, Inc., a leading developer of next-generation flexible stents, announced today it has received CE Mark for its FlexStent™ Biliary Self Expanding Stent System.
Benvenue Medical Receives CE Mark Approval for Kiva VCF Treatment System
Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, announced today that it has received CE Mark approval in Europe for the Kiva™ Vertebral Compression Fracture (VCF) Treatment System.